Real-Time Drug Interaction Checker for Bangladesh Doctors
Prevent adverse drug events with instant point-of-care alerts for drug-drug interactions, duplicate therapies, and clinical contraindications.
Multi-Level Severity Alerts
Classifies interactions into Major (avoid combination), Moderate (monitor therapy), and Minor severity levels with documented clinical evidence.
Therapeutic Duplication Checks
Instantly alerts physicians if multiple drugs with the same active ingredient or pharmacological class (e.g. dual NSAIDs, dual PPIs) are added.
Pregnancy & Lactation Warnings
Cross-checks FDA pregnancy risk categories (A, B, C, D, X) and lactation safety data to protect maternal and fetal health.
Organ-Specific Dosing Safeguards
Identifies nephrotoxic and hepatotoxic combinations, providing renal and hepatic dose reduction guidance at the moment of prescription.
Aligned with Bangladesh DGDA & WHO Protocols
All database indices, generic classifications, and dosage recommendations adhere strictly to the Directorate General of Drug Administration (DGDA) gazette, the Bangladesh National Formulary (BDNF), and evidence-based clinical protocols.
Frequently Asked Questions
Yes. The system automatically maps all 39,000+ local brand names (Square, Beximco, Incepta, etc.) to their underlying active generic molecules to evaluate interactions.
Yes. Clinical decision support is designed to assist, not override. Doctors can acknowledge the clinical alert and proceed with documented clinical reasoning.
Rules are derived from international evidence-based pharmacopeias, WHO prescribing guidelines, and the Bangladesh National Formulary (BDNF).
Ready to modernise your prescription practice?
Join verified doctors across Bangladesh prescribing with MedRx today.